Skip to content

Clinical trials

Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Clear all

1,482 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200029
200129
200216
200350
200443
200538
200650
200770
200871
200970
201061
201158
201256
201339
201461
201554
201657
201758
201845
201945
202059
202159
202251
202350
202453
202553
202661

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed882
Unknown status245
Recruiting136
Terminated71
Active, not recruiting58
Not yet recruiting40
Withdrawn37
Enrolling by invitation9
Suspended3
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)91
GlaxoSmithKline32
Novartis Pharmaceuticals22
Boston Scientific Corporation20
Massachusetts General Hospital20
AstraZeneca16
Korea University15
Organon and Co14
Assistance Publique - Hôpitaux de Paris12
Abbott Medical Devices11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis1,482
Cardiovascular Diseases354
Coronary Artery Disease267
Heart Diseases138
Inflammation125
Coronary Disease119
Peripheral Arterial Disease98
Diabetes Mellitus92
Stroke89
Myocardial Infarction84

Trials

Showing 51 to 75 of 1,482. Each trial links to its page on Pharma Observatory.

1,382 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.